Patients News | pharmaphorum

News

UK “keeping up momentum” on clinical trials review

Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive develo

News

Concerns voiced as Palantir wins £330m NHS data contract

NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framewor

News

EVERSANA taps Adobe Firefly in quest to ‘pharmatise’ GenAI

EVERSANA has taken another step forwards in its effort to put generative artificial intelligence (GenAI) at the heart of the pharma industry’s processes.

News

'Landmark' deal reached on UK voluntary rebate scheme

After months of wrangling, an agreement has finally been reached on a successor to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), the system of reve

News

ABPI says UK clinical trials sector ‘improving’

There are glimmers of a recovery in the UK’s clinical research sector, with an uptick in the number of new studies being started, according to a new report.

News

UK to make oral contraceptives available OTC next month

Starting next month, around half a million women will be able to get oral contraceptives from a pharmacy without seeing their doctor first, under changes introduced by NHS

UK “keeping up momentum” on clinical trials review

Concerns voiced as Palantir wins £330m NHS data contract

EVERSANA taps Adobe Firefly in quest to ‘pharmatise’ GenAI

'Landmark' deal reached on UK voluntary rebate scheme

ABPI says UK clinical trials sector ‘improving’

UK to make oral contraceptives available OTC next month

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks